Jian-Hong Zhong (Jianhong Zhong, J-H Zhong)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 52

Top Venues

Alimentary pharmacology & therapeutics

BJS open

Expert review of gastroenterology & hepatology

Journal of clinical and translational hepatology

Guangxi Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Guangxi Medical University Sep 01 2014 - Jun 30 2017

China

PHD

University of Illinois at Chicago Feb 01 2016 - Mar 01 2017

United States

PHD

Publications

Le Li, Zhen-Zhen Li, Li-Xin Pan, Jia-Yong Su, Shan Huang, Liang Ma, Jian-Hong Zhong
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions. Journal of clinical and translational hepatology 12 (5) (2024)
Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study. Infectious agents and cancer 19 (1) (2024)
Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study. Infectious agents and cancer 19 (1) (2024)
Li-Xin Pan, Yi-Yang Wang, Zhong-Hai Li, Jia-Xi Luo, Kun-Jun Wu, Zhen-Xiu Liu, Pei-Sheng Wu, Kang Chen, Liang Ma, Xiao-Hui Fan, Jian-Hong Zhong
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial. Trials 25 (1) (2024)
Rong-Rui Huo, Li-Xin Pan, Pei-Sheng Wu, Xiu-Mei Liang, Xue-Mei You, Liang Ma, Jian-Hong Zhong
Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy. BJS open 8 (1) (2024)
Li-Xin Pan, Yi-Yang Wang, Zhong-Hai Li, Jia-Xi Luo, Kun-Jun Wu, Zhen-Xiu Liu, Pei-Sheng Wu, Kang Chen, Liang Ma, Xiao-Hui Fan, Jian-Hong Zhong
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial. Trials 25 (1) (2024)
Jianrong Li, Dalong Yang, Jian-Hong Zhong, Yingyang Liao
Letter: Determining optimal ALT cut-off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (9) (2024)
Le Li, Zhen-Zhen Li, Li-Xin Pan, Jia-Yong Su, Shan Huang, Liang Ma, Jian-Hong Zhong
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions. Journal of clinical and translational hepatology 12 (5) (2024)
Zhu-Jian Deng, Hao-Tian Liu, Bao-Hong Yuan, Li-Xin Pan, Yu-Xian Teng, Jia-Yong Su, Cheng-Piao Luo, Ping-Ping Guo, Jian-Hong Zhong
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Jianrong Li, Dalong Yang, Jian-Hong Zhong, Yingyang Liao
Letter: Determining optimal ALT cut-off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 59 (9) (2024)
Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study. Infectious agents and cancer 19 (1) (2024)
Jia-Yong Su, Ying-Ling Wu, Xuan-Lin Wu, Zhen-Xiu Liu, Yi-Yang Wang, Zhong-Hai Li, Jia-Xin Luo, Kun-Jun Wu, Jian-Hong Zhong
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics 58 (8) (2023)
Jia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, Ye Xin Koh, Wan-Guang Zhang, Ming-Hua Zheng, Si Xie, Rong-Rui Huo, Chao-Jing Chen, Liang Ma, Jian-Hong Zhong
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis. BJS open 7 (1) (2023)
Hao-Tian Liu, Cheng-Piao Luo, Meng-Jie Jiang, Zhu-Jian Deng, Yu-Xian Teng, Jia-Yong Su, Li-Xin Pan, Liang Ma, Ping-Ping Guo, Jian-Hong Zhong
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Jian-Rong Li, Da-Long Yang, Jin-Ming Wang, Wei Tian, Wei Wei, Cheng-Piao Luo, Lu-Nan Qi, Liang Ma, Jian-Hong Zhong
Importance of optimizing duration of adjuvant immune checkpoint inhibitor therapy to treat postoperative hepatocellular carcinoma after conversion therapy: a case report. Journal of surgical case reports 2023 (11) (2023)
Yu-Xian Teng, Wan-Guang Zhang, Anthony Wing-Hung Chan, Charing Ching Ning Chong, Matteo Serenari, Yan-Yan Wang, Ning Peng, Tao Huang, Shi-Dong Lu, Zhi-Yin Liang, Liang Ma, Jian-Hong Zhong
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates. Alimentary pharmacology & therapeutics 57 (7) (2023)
Min-Jun Li, Yu-Xian Teng, Si Xie, Liang Ma, Le-Qun Li, Bang-De Xiang, Jian-Hong Zhong
Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus. Expert review of gastroenterology & hepatology (2023)
Min-Jun Li, Yu-Xian Teng, Si Xie, Liang Ma, Le-Qun Li, Bang-De Xiang, Jian-Hong Zhong
Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus. Expert review of gastroenterology & hepatology (2023)
Le Li, Pei-Sheng Wu, Xiu-Mei Liang, Kang Chen, Guan-Lan Zhang, Qi-Bin Su, Rong-Rui Huo, Rong-Wei Xie, Shan Huang, Liang Ma, Jian-Hong Zhong
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study. Journal of gastroenterology (2023)
Jia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, Ye Xin Koh, Wan-Guang Zhang, Ming-Hua Zheng, Si Xie, Rong-Rui Huo, Chao-Jing Chen, Liang Ma, Jian-Hong Zhong
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis. BJS open 7 (1) (2023)
Jun Tao Huang, Jian-Hong Zhong, Jie Zhang, Wen Feng Gong, Liang Ma, Le Qun Li, Bang-De Xiang
Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol. BMJ open 13 (9) (2023)
Jia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, Ye Xin Koh, Wan-Guang Zhang, Ming-Hua Zheng, Si Xie, Rong-Rui Huo, Chao-Jing Chen, Liang Ma, Jian-Hong Zhong
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis. BJS open 7 (1) (2023)
Bao-Hong Yuan, Yan-Kun Zhu, Xu-Ming Zou, Hao-Dong Zhou, Ru-Hong Li, Jian-Hong Zhong
Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis. BJS open 6 (2) (2022)
Le Li, Hao-Tian Liu, Yu-Xian Teng, Zhu-Jian Deng, Guan-Lan Zhang, Jia-Yong Su, Liang Ma, Jian-Hong Zhong
Second-line treatment options for hepatocellular carcinoma: current state and challenges for the future. Expert opinion on investigational drugs (2022)
Zhen Wang, Miao Liu, De-Zhi Zhang, Song-Song Wu, Zhi-Xian Hong, Guang-Bin He, Hong Yang, Bang-de Xiang, Xiao Li, Tian-An Jiang, Kai Li, Zhe Tang, Fei Huang, Man Lu, Ji-An Chen, Yu-Cheng Lin, Xiao Lu, Yu-Quan Wu, Xiao-Wu Zhang, Ye-Fan Zhang, Chao Cheng, Huo-Lin Ye, Lan-Tian Wang, Hua-Ge Zhong, Jian-Hong Zhong, Lu Wang, Miao Chen, Fang-Fang Liang, Yi Chen, Yan-Song Xu, Xiao-Ling Yu, Zhi-Gang Cheng, Fang-Yi Liu, Zhi-Yu Han, Wei-Zhong Tang, Jie Yu, Ping Liang
Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC. Hepatology (Baltimore, Md.) 76 (1) (2022)
Yu-Xian Teng, Si Xie, Ping-Ping Guo, Zhu-Jian Deng, Zi-Yi Zhang, Wei Gao, Wan-Guang Zhang, Jian-Hong Zhong
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges. Journal of clinical and translational hepatology 10 (5) (2022)
Bao-Hong Yuan, Ru-Hong Li, Rong-Rui Huo, Min-Jun Li, Georgios Papatheodoridis, Jian-Hong Zhong
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis. Journal of gastroenterology and hepatology 37 (5) (2022)
Kang Chen, Wei Wei, Lei Liu, Zhu-Jian Deng, Le Li, Xiu-Mei Liang, Ping-Ping Guo, Lu-Nan Qi, Zhi-Ming Zhang, Wen-Feng Gong, Shan Huang, Wei-Ping Yuan, Liang Ma, Bang-De Xiang, Le-Qun Li, Jian-Hong Zhong
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice. Cancer immunology, immunotherapy : CII (2021)
Jian-Hong Zhong, B-C Xing, W-G Zhang, A W-H Chan, Charing Ching Ning Chong, M Serenari, N Peng, T Huang, S-D Lu, Z-Y Liang, R-R Huo, Y-Y Wang, M Cescon, T-Q Liu, L Li, F-X Wu, L Ma, M Ravaioli, J Neri, A Cucchetti, P J Johnson, L-Q Li, B-D Xiang
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study. The British journal of surgery (2021)
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of clinical and translational hepatology 10 (1) (2021)
Hong-Lin Luo, Tao Luo, Jun-Jie Liu, Fei-Xiang Wu, Tao Bai, Chao Ou, Jie Chen, Le-Qun Li, Jian-Hong Zhong
Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway. Cancer cell international 21 (1) (2021)
Dun-Chang Mo, Rong-Rong Jia, Jian-Hong Zhong
Letter to the Editor: Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward. Hepatology (Baltimore, Md.) 70 (1) (2020)
Zhu-Jian Deng, Hao-Tian Liu, Wen-Feng Gong, Bang-De Xiang, Jian-Hong Zhong
Letter: sex disparity in prognosis of patients with hepatocellular carcinoma after resection. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Chuan Li, Zhi-Cheng Li, Liang Ma, Le-Qun Li, Jian-Hong Zhong, Bang-De Xiang, Wen-Feng Gong
Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Expert review of gastroenterology & hepatology 14 (8) (2020)
Yu-Xian Teng, Min-Jun Li, Bang-De Xiang, Jian-Hong Zhong
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis. Gut 69 (10) (2019)
Wen-Feng Gong, Jian-Hong Zhong, Zhan Lu, Qiu-Ming Zhang, Zhi-Yuan Zhang, Chang-Zhi Chen, Xu Liu, Liang Ma, Zhi-Ming Zhang, Bang-De Xiang, Le-Qun Li
Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Bioscience reports 39 (8) (2019)
Yan-Ji Jiang, Jian-Hong Zhong, Zi-Han Zhou, Mo-Qin Qiu, Xian-Guo Zhou, Ying-Chun Liu, Rong-Rui Huo, Xiu-Mei Liang, Zhu Chen, Qiu-Ling Lin, Xiang-Yuan Yu, Hong-Ping Yu
Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma. Cancer medicine 8 (5) (2019)
Rong-Rong Jia, Jian-Hong Zhong, Rong-Rui Huo, Qi-Bin Su, Xiao Xiang, Fu-Lin Zhao, Zhong-Bian Qin, Jia-Hao Chen, Ying-Yang Liao, Liang Ma, Bang-De Xiang, Chun-Yan Zhang, Le-Qun Li
Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy. Journal of surgical oncology 119 (6) (2019)
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K Ahir, Wan-Guang Zhang, Jian-Hong Zhong
Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert review of gastroenterology & hepatology 13 (11) (2019)
Jian-Hong Zhong, Xiao Xiang, Yan-Yan Wang, Xu Liu, Lu-Nan Qi, Cheng-Piao Luo, Wen-E Wei, Xue-Mei You, Liang Ma, Bang-De Xiang, Le-Qun Li
The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression. Journal of cellular physiology 235 (2) (2019)
X-J Kuang, R-R Jia, R-R Huo, J-J Yu, J-J Wang, B-D Xiang, L-Q Li, Z Peng, Jian-Hong Zhong
Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Journal of viral hepatitis 25 (9) (2018)
Lu-Nan Qi, Bang-De Xiang, Fei-Xiang Wu, Jia-Zhou Ye, Jian-Hong Zhong, Yan-Yan Wang, Yuan-Yuan Chen, Zu-Shun Chen, Liang Ma, Jie Chen, Wen-Feng Gong, Ze-Guang Han, Yan Lu, Jin-Jie Shang, Le-Qun Li
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer research 78 (16) (2018)
Yan-Yan Wang, Jian-Hong Zhong, Xin-Hua Zhao, Le-Qun Li
The role of SSM and LSPS in predicting posthepatectomy liver failure should be further evaluated. Journal of surgical oncology 119 (3) (2018)
Fang Su, Kai-Hua Chen, Zhong-Guo Liang, Chun-Hua Wu, Ling Li, Song Qu, Long Chen, Xiao-Dong Zhu, Jian-Hong Zhong, Le-Qun Li, Bang-De Xiang
Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus. Cancer medicine 7 (9) (2018)
Han-Yue Mo, Ying-Yang Liao, Xue-Mei You, Alessandro Cucchetti, Bao-Hong Yuan, Ru-Hong Li, Jian-Hong Zhong, Le-Qun Li
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PloS one 12 (3) (2017)
Ying-Yang Liao, Ning-Fu Peng, Di Long, Peng-Cheng Yu, Sen Zhang, Jian-Hong Zhong, Le-Qun Li
Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC surgery 17 (1) (2017)
C-Y Zhang, B-K Ahir, G-B Wu, Jian-Hong Zhong, L-Q Li
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Alimentary pharmacology & therapeutics 46 (5) (2017)
X-Y Zhang, R-R Jia, X Xiang, W-F Gong, B-D Xiang, Jian-Hong Zhong, L-Q Li
Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance. Alimentary pharmacology & therapeutics 46 (9) (2017)
Alessandro Cucchetti, Alberta Cappelli, Cristina Mosconi, Jian-Hong Zhong, Matteo Cescon, Antonio D Pinna, Rita Golfieri
Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study. Liver international : official journal of the International Association for the Study of the Liver 37 (7) (2017)
C Zhao, S-L Pei, A Cucchetti, T-J Tong, Y-L Ma, Jian-Hong Zhong, L-Q Li
Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. Alimentary pharmacology & therapeutics (2017)
Xiao Xiang, Hong-Gui Qin, Xue-Mei You, Yan-Yan Wang, Lu-Nan Qi, Liang Ma, Bang-De Xiang, Jian-Hong Zhong, Le-Qun Li
Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure. Cancer medicine 6 (10) (2017)
Han-Yue Mo, Bang-De Xiang, Jian-Hong Zhong, Le-Qun Li, Xue-Mei You
Comment on "Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis". Canadian journal of gastroenterology & hepatology 2016 (2016)

Jian-Hong Zhong.css-eqlu8i{font-size:small;padding-left:4px;} (Jianhong Zhong, J-H Zhong)

Publication Activity (10 Years)

Top Topics

Top Venues

Jian-Hong Zhong (Jianhong Zhong, J-H Zhong)